ArticleScientific reports2023

A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner.

Jian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.